Authors :
Nayan Ghosh Biswas; Sazedur Rahman Akanda; Dr. Mohibul Hoque; Debosmita Hore
Volume/Issue :
Volume 7 - 2022, Issue 1 - January
Google Scholar :
http://bitly.ws/gu88
Scribd :
https://bit.ly/3IFgRT7
Abstract :
The orthodox group of antipsychotic drugs,
used for almost more than half era to treat a wide range
of psychiatric ailments are now being swapped in clinical
as well as medical relates by contemporary ‘atypicalantipsychotis’, which embraces risperidone,
aripiprazole, olanzapine clozapine, ziprasidone and
others. As a category, the new xenobiotics have been
uplifted as being widely superior in clinical benefits, but
the indication for this is quite challenging. In the present
expository review, the therapeutic benefits,
pharmacologic aspects, untoward effects, tolerability and
process and product cost efficiency of the current agents
are taken into consideration in contrast to the existing
antipsychotics. Due to the stereotypically negligible
differences between agents of the two eras in terms of the
above mentioned clinical aspects and moreover because
of the mounting concerns about possible opposing effects
and chronic health penalties of some of the modern
antipsychotic drugs, it is rational to ponder both older as
well as newer agents for clinical usage and moreover it is
also vital to notify patients about the considerable risks,
benefits and costs of explicit selections of the same
Keywords :
Atypical, antipsychotics, xenobiotics, untoward effect, tolerability
The orthodox group of antipsychotic drugs,
used for almost more than half era to treat a wide range
of psychiatric ailments are now being swapped in clinical
as well as medical relates by contemporary ‘atypicalantipsychotis’, which embraces risperidone,
aripiprazole, olanzapine clozapine, ziprasidone and
others. As a category, the new xenobiotics have been
uplifted as being widely superior in clinical benefits, but
the indication for this is quite challenging. In the present
expository review, the therapeutic benefits,
pharmacologic aspects, untoward effects, tolerability and
process and product cost efficiency of the current agents
are taken into consideration in contrast to the existing
antipsychotics. Due to the stereotypically negligible
differences between agents of the two eras in terms of the
above mentioned clinical aspects and moreover because
of the mounting concerns about possible opposing effects
and chronic health penalties of some of the modern
antipsychotic drugs, it is rational to ponder both older as
well as newer agents for clinical usage and moreover it is
also vital to notify patients about the considerable risks,
benefits and costs of explicit selections of the same
Keywords :
Atypical, antipsychotics, xenobiotics, untoward effect, tolerability
